Formulary and Therapeutic Interchanges
3rd Quarter 2025
Class | Non-preferred | Alternative |
---|---|---|
ANTIDIABETICS | Basaglar, Toujeo Solostar, Admelog Solo, Mounjaro, Rybelsus | Insulin Lisp, Insulin Lispro Kwik, Insulin Aspart, Insulin Aspart Kwik, Trulicity,* Ozempic* |
STIMULANTS AND RELATED ADHD DRUGS | Focalin XR, Focalin, Adhansia Xr, Aptensio XR, Jornay PM, Mydayis, Strattera, Intuniv | Dexmethylphenidate, Dexmethylphenidate ER, Amphetamine salt combination ER, Methylphenidate, Atomoxetine, Guanfacine, Qelbree |
ANTIASTHMATIC AND BRONCHODILATOR AGENTS | Budesonide/ formoterol, Proair Respiclick, Fluticasone/ salmeterol, Wixela, Inhub, Budesonide | Fluticasone HFA, Albuterol HFA, Advair Diskus, Advair HFA, Combivent |
ANTIDEPRESSANTS | Aplenzin, Trintellix, Fetzima, Spravato | Bupropion Hcl, Lurasidone, Desvenlafaxine, Escitalopram, Vilazodone |
GASTROINTESTINAL AGENTS - MISC. | Canasa, Dexilant, Amitiza, | Apriso, Lialda, Esomeprazole, Lubiprostone |
*May require Prior Authorization
Abbreviations: ER = extended-release, XR = extended-release